REGISTER
FOR TESTING
ACCESS REPORTS
REGISTER
FOR TESTING
ACCESS REPORTS
REGISTER
FOR TESTING
Non-Invasive Prenatal Testing (NIPT) is a blood screening test performed as early as 10 weeks of pregnancy. It analyzes fetal DNA (cfDNA) in the mother's blood to screen for common chromosomal disorders like trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), and trisomy 13 (Patau syndrome), and can also determine the fetus’s sex.
Our advanced NIPT uses multiplex PCR technology to detect aneuploidy for chromosomes 21, 18, and 13, along with fetal fraction and gender determination, offering a comprehensive view of fetal health.
